Why the study?
African swine fever poses an existential threat to the global swine industry with high mortality and rapid spread, creating an immediate need for effective vaccines for response and recovery.
Highlights the urgent need for effective vaccines to control the spread and economic impact of African Swine Fever.
Answers are grounded in this paper and cite their sources.
ASF endemicity outside Africa heightens swine biosecurity needs; leaves open vaccine and control strategies.
African swine fever (ASF) is an acute viral hemorrhagic disease of domestic swine with mortality rates approaching 100%. Devastating ASF outbreaks and continuing epidemics starting in the Caucasus region and now in the Russian Federation, Europe, China, and other parts of Southeast Asia (2007 to date) highlight its significance. ASF strain Georgia-07 and its derivatives are now endemic in extensive regions of Europe and Asia and are "out of Africa" forever, a situation that poses a grave if not an existential threat to the swine industry worldwide. While our current concern is Georgia-07, other emerging ASFV strains will threaten for the indefinite future. Economic analysis indicates that an ASF outbreak in the U.S. would result in approximately $15 billion USD in losses, assuming the disease is rapidly controlled and the U.S. is able to reenter export markets within two years. ASF's potential to spread and become endemic in new regions, its rapid and efficient transmission among pigs, and the relative stability of the causative agent ASF virus (ASFV) in the environment all provide significant challenges for disease control. Effective and robust methods, including vaccines for ASF response and recovery, are needed immediately.
No takes yet. Share an insight, caveat, or question.
Daniel L. Rock (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: